ADVFN Logo

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

MDNA Medicenna Therapeutics Corp

1,86
0,17 (10,06%)
28 Mar 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Medicenna Therapeutics Corp MDNA Toronto Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,17 10,06% 1,86 21:23:59
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,75 1,71 2,10 1,86 1,69
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/3/202413:00GLOBEMedicenna to Provide Clinical Update on the MDNA11 ABILITY-1..
14/2/202413:30GLOBEMedicenna Therapeutics Reports Third Quarter Fiscal 2024..
13/2/202413:00GLOBEMedicenna Announces First Patient Dosed in ABILITY-1 Study..
12/1/202423:36GLOBEMedicenna Announces Appointment of New Auditor
09/1/202413:00GLOBEMedicenna Commences Enrollment in the ABILITY-1 Study..
22/12/202301:30GLOBEMedicenna Extends Period to Exercise Certain Warrants
19/12/202313:00GLOBEMedicenna Announces Trading on the OTCQB Under the Symbol..
14/11/202314:30GLOBEMedicenna Therapeutics Reports Second Quarter Fiscal 2024..
09/11/202314:56GLOBEMedicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp..
06/11/202313:00GLOBEMedicenna Announces Promising Single-Agent Response and..
03/11/202317:00GLOBEMedicenna Presents Preclinical Data on MDNA113, its Targeted..
27/10/202313:55GLOBEMedicenna Announces Nasdaq Delisting and Cutback of..
25/10/202313:00GLOBEMedicenna Therapeutics Doses First Patient in Phase 2..
24/10/202313:15GLOBEMedicenna Announces Presentations at the 38th Annual Meeting..
10/10/202313:07GLOBEMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as..
03/10/202313:00GLOBEMedicenna Presents Preclinical MDNA223 BiSKIT Data at the..
28/9/202323:00GLOBEMedicenna Announces Results of Annual and Special Meeting of..
28/9/202313:00GLOBEMedicenna to Present at the AACR Special Conference Cancer..
06/9/202313:00GLOBEMedicenna to Participate at The H.C. Wainwright 25th Annual..
28/8/202313:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
14/8/202313:00GLOBEMedicenna Establishes Boston Presence, Appoints Brent..
08/8/202313:00GLOBEMedicenna Appoints Dr. Arash Yavari as Chair of Development..
04/8/202313:00GLOBEMedicenna Therapeutics to Provide Clinical Update from Phase..
01/8/202315:30GLOBEMedicenna Strengthens IP Portfolio with U.S. Patent Granted..
28/7/202313:00GLOBEMedicenna Reports First Quarter Fiscal 2024 Financial..
25/7/202313:00GLOBEMedicenna Presents at National Brain Tumor Society's..
05/7/202313:00GLOBEMedicenna Extends Period to Exercise Certain Warrants
27/6/202314:00GLOBEMedicenna Reports Fiscal Year 2023 Financial Results and..
27/4/202313:00GLOBEMedicenna Granted 180-Day Extension to Meet Nasdaq Minimum..
18/4/202313:00GLOBEMedicenna to Present at the 2023 Bloom Burton & Co...
17/4/202313:00GLOBEMedicenna Presents Preclinical IL-13 Superkine Data at the..

Dernières Valeurs Consultées

Delayed Upgrade Clock